Pre-Open Stock Movers:
Teladoc (NYSE:TDOC) 44% LOWER; reported Q1 EPS of ($41.58), which may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million versus the consensus estimate of $568.8 million. Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6 billion or $41.11 per share. Teladoc sees FY2022 EPS of ($43.50)-($43.00), may not compare versus the consensus of ($1.53). Teladoc sees FY2022 revenue of $2.4-2.5 billion, versus the consensus of $2.58 billion.
Sio Gene Therapies Inc. (SIOX) 36% LOWER; provided the required notice to the University of Massachusetts to terminate its licensing agreement to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM2, for the treatment of GM1 gangliosidosis and GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease), respectively.
Align Technology (NASDAQ:ALGN) 21% LOWER; reported Q1 EPS of $2.13, $0.09 worse than the analyst estimate of $2.22. Revenue for the quarter came in at $973.2 billion versus the consensus estimate of $1 billion.
LendingClub (NYSE:LC) 16% HIGHER; reported Q1 EPS of $0.39, $0.15 better than the analyst estimate of $0.24. Revenue for the quarter came in at $289.5 million versus the consensus estimate of $262.07 million. LendingClub sees FY2022 revenue of $1.15-1.25 billion, versus the consensus of $1.16 billion. LendingClub sees Q2 2022 revenue of $295-305 million, versus the consensus of $284.8 million.
Meta Platforms (FB) 14% HIGHER; reported Q1 EPS of $2.72, $0.16 better than the analyst estimate of $2.56. Revenue for the quarter came in atwhich ersus the consensus of $30.6 billion
Upwork Inc. (NASDAQ:UPWK) 13.5% HIGHER; reported Q1 EPS of ($0.03), $0.11 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $141.3 million versus the consensus estimate of $136.3 million. Upwork Inc. sees Q2 2022 EPS of ($0.06)-($0.10), versus the consensus of ($0.08). Upwork Inc. sees Q2 2022 revenue of $147-151 million, versus the consensus of $143.45 million. Upwork Inc. sees FY2022 revenue of $590-610 million, versus the consensus of $599 million.
Atomera Incorporated (ATOM) 13% HIGHER; announced that it has entered into a new Joint Development Agreement with a major semiconductor foundry.
Greenhill & Co. (NYSE:GHL) 10% LOWER; reported Q1 EPS of ($0.66), $0.86 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $70.12 million.
Pinterest (NYSE:PINS) 9% HIGHER; reported Q1 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $575 million versus the consensus estimate of $572.94 million.
ServiceNow (NYSE:NOW) 8% HIGHER; reported Q1 EPS of $1.73, $0.03 better than the analyst estimate of $1.70. Revenue for the quarter came in at $1.72 billion versus the consensus estimate of $1.7 billion. Sees Q2 Subscription revenues OF $1.67-$1.675 billion.
O'Reilly Automotive (NASDAQ:ORLY) 7% LOWER; reported Q1 EPS of $7.17, $0.31 worse than the analyst estimate of $7.48. Revenue for the quarter came in at $3.3 billion versus the consensus estimate of $3.32 billion. O'Reilly Automotive sees FY2022 revenue of $14.2-14.5 billion, versus the consensus of $14.4 billion.
Qualcomm (NASDAQ:QCOM) 6% HIGHER; reported Q2 EPS of $3.21, $0.30 better than the analyst estimate of $2.91. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $10.6 billion. Qualcomm sees Q3 2022 EPS of $2.75-$2.95, versus the consensus of $2.59. Qualcomm sees Q3 2022 revenue of $10.5-11.3 billion, versus the consensus of $9398 billion.
Amgen (NASDAQ:AMGN) 5% LOWER; the IRS is seeking $7.1 billion in back taxes and penalties related to the allocation of profits between certain of its entities in the U.S. and Puerto Rico. The company also reported Q1 EPS of $4.25, $0.15 better than the analyst estimate of $4.10. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.07 billion.
Domino's Pizza (NYSE:DPZ) 5% LOWER; reported Q1 EPS of $2.50, $0.55 worse than the analyst estimate of $3.05. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1.03 billion.
Eli Lilly & Co. (NYSE:LLY) 3% HIGHER; reported Q1 EPS of $2.62, $0.49 better than the analyst estimate of $2.13. Revenue for the quarter came in at $7.81 billion versus the consensus estimate of $6.68 billion. Eli Lilly & Co. sees FY2022 EPS of $8.15-$8.30, versus the consensus of $8.19. The company sees revenue to be between $28.8 billion and $29.3 billion vs consensus of $26.8 billion.